Biosafe cerium oxide nanozymes protect human pluripotent stem cells and cardiomyocytes from oxidative stress

Chengwen Hang, Mohamed S. Moawad, Zheyi Lin, Huixin Guo, Hui Xiong, Mingshuai Zhang, Renhong Lu, Junyang Liu, Dan Shi, Duanyang Xie, Yi Liu, Dandan Liang, Yihan Chen, Jian YangJournal of Nanobiotechnology 2024 · DOI

Abstract

Cerium oxide nanozymes (CeONZs) displayed good safety and biocompatibility, as well as enhanced the cell viability of human embryonic stem cells (hESCs) and hESC-derived cardiomyocytes (hESC-CMs) by shielding them from oxidative damage. These promising results suggest that CeONZs may be crucial, as a safe nanoantioxidant, to potentially improve the therapeutic efficacy of cardiovascular diseases (CVDs) and be incorporated into regenerative medicine.

Introduction: The Challenge of Oxidative Stress in Regenerative Medicine

Human pluripotent stem cells (hPSCs) and their derived cardiomyocytes (hPSC-CMs) represent a cornerstone of modern regenerative medicine and drug discovery. However, these cells are exceptionally sensitive to their environment. Routine laboratory procedures—such as cell dissociation (passaging) or directed differentiation—often trigger the overproduction of Reactive Oxygen Species (ROS). While ROS are essential signaling molecules at low levels, their accumulation leads to oxidative stress, resulting in DNA damage, programmed cell death (apoptosis), and impaired cellular function.

Traditional antioxidants like Vitamin C or E are frequently employed to mitigate these effects, but they suffer from chemical instability, heat sensitivity, and poor bioavailability. There is a pressing need for stable, long-acting antioxidant solutions that can protect these delicate cell populations without compromising their pluripotency or functional characteristics.

Methodology: Engineering Synthetic Antioxidant Enzymes

Researchers synthesized Cerium Oxide Nanozymes (CeONZs) using a chemical precipitation method, stabilized with ethylene glycol to ensure high biocompatibility. These nanozymes are designed to mimic the activity of two vital natural enzymes:

  1. Superoxide Dismutase (SOD): Catalyzes the conversion of superoxide radicals into hydrogen peroxide.
  2. Catalase (CAT): Facilitates the breakdown of hydrogen peroxide into water and oxygen.

The study utilized H9 human embryonic stem cells and hESC-derived cardiomyocytes (verified at >95% purity). Validation included high-resolution imaging (TEM, XRD), functional electrophysiology via Microelectrode Arrays (MEA), and contractility measurements using IonOptix systems.

Key Findings and Mechanisms

The study revealed that CeONZs are rapidly internalized by cells via endocytosis and specifically localize within the mitochondria—the primary site of ROS generation. This strategic positioning allows the nanozymes to neutralize oxidative threats at their source.

Graphical abstract illustrating the mechanism of CeONZ cellular entry, ROS scavenging, and protection of hPSCs and hPSC-CMs from stress-induced apoptosis.

Protection Against Laboratory Stress

During the high-stress process of cell dissociation, CeONZs significantly reduced apoptosis and improved the colony-forming efficiency of hESCs. In models of acute oxidative stress (induced by $H_2O_2$), treatment with low-dose CeONZs (0.375 µM) increased cell viability from approximately 30% to 40%.

Mitigating Chemotherapy-Induced Cardiotoxicity

A significant application of CeONZs is their ability to protect heart cells from Doxorubicin (DOX), a potent chemotherapy drug known for its severe cardiotoxic side effects. In cardiomyocytes treated with 5 µM DOX, the addition of CeONZs nearly halved the rate of apoptosis, reducing it from 40% to roughly 22%. Crucially, the nanozymes did not interfere with the normal beating frequency or electrical conductivity of the heart cells.

Discussion and Future Directions

While these results are promising, several challenges remain for clinical translation. The current study was conducted in 2D cell cultures; future research must validate these findings in 3D organoid models that better replicate human cardiac tissue. Additionally, developing targeted delivery systems to ensure CeONZs reach the heart in vivo without being cleared by the reticuloendothelial system is a priority. Finally, the long-term metabolic fate and clearance of cerium from human tissues require extended longitudinal study.

Conclusion

CeONZs represent a robust, "biosafe" nanoantioxidant platform. By mimicking natural enzyme systems and targeting mitochondrial ROS, they offer a powerful tool for improving the survival and function of stem cells and cardiomyocytes, potentially enhancing the success of cardiac regenerative therapies.

Reference: Hang et al. Journal of Nanobiotechnology (2024) 22:132. https://doi.org/10.1186/s12951-024-02383-x

Summary updated

Abstract

CeONZs displayed good safety and biocompatibility, as well as enhanced the cell viability of hESCs and hESC-CMs by shielding them from oxidative damage. These promising results suggest that CeONZs may be crucial, as a safe nanoantioxidant, to potentially improve the therapeutic efficacy of CVDs and be incorporated into regenerative medicine.
BibTeX
@article{hang2024biosafe,
  author = {Chengwen Hang and Mohamed S. Moawad and Zheyi Lin and Huixin Guo and Hui Xiong and Mingshuai Zhang and Renhong Lu and Junyang Liu and Dan Shi and Duanyang Xie and Yi Liu and Dandan Liang and Yihan Chen and Jian Yang},
  title = {{Biosafe cerium oxide nanozymes protect human pluripotent stem cells and cardiomyocytes from oxidative stress}},
  journal = {Journal of Nanobiotechnology},
  year = {2024},
  doi = {10.1186/s12951-024-02383-x},
}
Figure